CN101868236A - 用于治疗胃食管返流性疾病的组合物 - Google Patents

用于治疗胃食管返流性疾病的组合物 Download PDF

Info

Publication number
CN101868236A
CN101868236A CN200880101836A CN200880101836A CN101868236A CN 101868236 A CN101868236 A CN 101868236A CN 200880101836 A CN200880101836 A CN 200880101836A CN 200880101836 A CN200880101836 A CN 200880101836A CN 101868236 A CN101868236 A CN 101868236A
Authority
CN
China
Prior art keywords
patient
proton pump
pump inhibitor
gerd
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880101836A
Other languages
English (en)
Chinese (zh)
Inventor
S·努尔拜
S·B·兰多
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dynogen Pharmaceuticals Inc
Original Assignee
Dynogen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynogen Pharmaceuticals Inc filed Critical Dynogen Pharmaceuticals Inc
Publication of CN101868236A publication Critical patent/CN101868236A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CN200880101836A 2007-06-07 2008-06-04 用于治疗胃食管返流性疾病的组合物 Pending CN101868236A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93353507P 2007-06-07 2007-06-07
US60/933,535 2007-06-07
PCT/US2008/007038 WO2008153884A1 (en) 2007-06-07 2008-06-04 Compositions useful for treating gastroesophageal reflux disease

Publications (1)

Publication Number Publication Date
CN101868236A true CN101868236A (zh) 2010-10-20

Family

ID=39619385

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880101836A Pending CN101868236A (zh) 2007-06-07 2008-06-04 用于治疗胃食管返流性疾病的组合物

Country Status (8)

Country Link
US (3) US20090131471A1 (enExample)
EP (1) EP2152263A1 (enExample)
JP (1) JP2010529125A (enExample)
CN (1) CN101868236A (enExample)
AU (1) AU2008262438A1 (enExample)
CA (1) CA2690581A1 (enExample)
RU (1) RU2009149637A (enExample)
WO (1) WO2008153884A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5692838B2 (ja) * 2009-12-15 2015-04-01 公立大学法人横浜市立大学 感覚器障害モデル動物
US20120225922A1 (en) * 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
JP3927738B2 (ja) * 1999-10-25 2007-06-13 キヤノン株式会社 通信システム
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물

Also Published As

Publication number Publication date
AU2008262438A1 (en) 2008-12-18
WO2008153884A1 (en) 2008-12-18
US20100247584A1 (en) 2010-09-30
WO2008153884A8 (en) 2009-03-26
US20110275667A1 (en) 2011-11-10
JP2010529125A (ja) 2010-08-26
EP2152263A1 (en) 2010-02-17
CA2690581A1 (en) 2008-12-18
US20090131471A1 (en) 2009-05-21
RU2009149637A (ru) 2011-07-20

Similar Documents

Publication Publication Date Title
RU2672248C1 (ru) Применение производного бензимидазола для лечения ночного кислотного прорыва
JP2011157372A (ja) 機能性腸障害を処置する方法
CN104337813A (zh) 使用维生素b组合物促进胃肠系统动力的方法
US10668034B2 (en) Pharmaceutical compositions and the treatment of overactive bladder
Jiang et al. Mechanism of stretch-activated excitatory and inhibitory responses in the lower esophageal sphincter
US20090048287A1 (en) Compositions useful for treating gastrointestinal motility disorders
UA122974C2 (uk) Комбінований лікарський засіб, який містить канагліфлозин і фентермін, для лікування ожиріння й пов'язаних з ожирінням порушень
CN101868236A (zh) 用于治疗胃食管返流性疾病的组合物
KR101901001B1 (ko) PPAR-β 길항제를 포함하는 항암 효과 증진용 약학적 조성물
JP5908072B2 (ja) 腹圧性尿失禁予防剤及び／又は治療剤
CN102695508A (zh) 阿片样受体拮抗剂用于胃肠道疾病的用途
KR20150036115A (ko) 위식도 역류증에 대한 약제
KR102900177B1 (ko) 내장통 또는 내장 질환에서 기인한 통증을 예방, 경감 또는 치료하기 위한 카바메이트 화합물의 용도
US20250381180A1 (en) Methods of treating or preventing overactive bladder syndrome
TWI676477B (zh) 苯并咪唑衍生物用於夜間酸突破的用途
US20080269276A1 (en) Compositions useful for treating irritable bowel syndrome
Walt et al. Essential drugs in anesthetic practice
Van Rensburg Men's health-heartburn: family feature
HK1228804A1 (en) 5-ht4 receptor agonist for gastroparesis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20101020